These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 19104410
1. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients. van Ree RM, Oterdoom LH, de Vries AP, Homan van der Heide JJ, van Son WJ, Navis G, Gans RO, Bakker SJ. Transplantation; 2008 Dec 27; 86(12):1713-9. PubMed ID: 19104410 [Abstract] [Full Text] [Related]
2. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease. Liakopoulos V, Eleftheriadis T, Kyropoulos T, Voliotis G, Potamianos S, Zengos N, Stefanidis I, Heintz B. Ren Fail; 2005 Dec 27; 27(3):315-21. PubMed ID: 15957549 [Abstract] [Full Text] [Related]
3. Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Suliman ME, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P. Nephrol Dial Transplant; 2006 Jun 27; 21(6):1603-10. PubMed ID: 16476720 [Abstract] [Full Text] [Related]
4. Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients. van Ree RM, Gross S, Zelle DM, van der Heide JJ, Schouten JP, van Son WJ, Gans RO, Bakker SJ. Transplantation; 2010 May 27; 89(10):1247-54. PubMed ID: 20559032 [Abstract] [Full Text] [Related]
5. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nelson CL, Karschimkus CS, Dragicevic G, Packham DK, Wilson AM, O'Neal D, Becker GJ, Best JD, Jenkins AJ. Nephrol Dial Transplant; 2005 Nov 27; 20(11):2420-6. PubMed ID: 16115854 [Abstract] [Full Text] [Related]
8. N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population. Oterdoom LH, de Vries AP, van Ree RM, Gansevoort RT, van Son WJ, van der Heide JJ, Navis G, de Jong PE, Gans RO, Bakker SJ. Transplantation; 2009 May 27; 87(10):1562-70. PubMed ID: 19461495 [Abstract] [Full Text] [Related]
9. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Glowinska B, Urban M, Peczynska J, Florys B. Metabolism; 2005 Aug 27; 54(8):1020-6. PubMed ID: 16092051 [Abstract] [Full Text] [Related]
13. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Stinghen AE, Gonçalves SM, Martines EG, Nakao LS, Riella MC, Aita CA, Pecoits-Filho R. Nephron Clin Pract; 2009 Aug 27; 111(2):c117-26. PubMed ID: 19147993 [Abstract] [Full Text] [Related]
14. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Brevetti G, Martone VD, de Cristofaro T, Corrado S, Silvestro A, Di Donato AM, Bucur R, Scopacasa F. Thromb Haemost; 2001 Jan 27; 85(1):63-6. PubMed ID: 11204590 [Abstract] [Full Text] [Related]
16. Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia. Rosenson RS, Wolff D, Tangney CC. Clin Sci (Lond); 2004 Feb 27; 106(2):215-7. PubMed ID: 12967321 [Abstract] [Full Text] [Related]
17. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Karbowska A, Boratynska M, Kusztal M, Klinger M. Transplant Proc; 2009 Oct 27; 41(8):3052-5. PubMed ID: 19857674 [Abstract] [Full Text] [Related]
18. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. J Am Soc Nephrol; 2006 Feb 27; 17(2):537-45. PubMed ID: 16382015 [Abstract] [Full Text] [Related]
19. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease. Shai I, Pischon T, Hu FB, Ascherio A, Rifai N, Rimm EB. Obesity (Silver Spring); 2006 Nov 27; 14(11):2099-106. PubMed ID: 17135628 [Abstract] [Full Text] [Related]
20. Effect of allergen immunotherapy on soluble adhesion molecules. Pereira-Santos MC, Pregal AL, Spínola-Santos A, Alonso E, Palma-Carlos ML, Palma-Carlos AG. Allerg Immunol (Paris); 2001 Jun 27; 33(6):225-8. PubMed ID: 11505805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]